Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Netherlands Is on Track to Meet the World Health Organization Hepatitis C Elimination Targets by 2030.
van Dijk M, Brakenhoff SM, Isfordink CJ, Cheng WH, Blokzijl H, Boland G, Dofferhoff ASM, van Hoek B, van Nieuwkoop C, Sonneveld MJ, van der Valk M, Drenth JPH, de Knegt RJ. van Dijk M, et al. Among authors: van nieuwkoop c, van hoek b, van der valk m. J Clin Med. 2021 Sep 30;10(19):4562. doi: 10.3390/jcm10194562. J Clin Med. 2021. PMID: 34640576 Free PMC article.
Gamma-glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-alpha-2b in chronic hepatitis C non-responders.
Bergmann JF, Vrolijk JM, van der Schaar P, Vroom B, van Hoek B, van der Sluys Veer A, de Vries RA, Verhey E, Hansen BE, Brouwer JT, Janssen HL, Schalm SW, de Knegt RJ. Bergmann JF, et al. Among authors: van hoek b, van der schaar p, van der sluys veer a. Liver Int. 2007 Nov;27(9):1217-25. doi: 10.1111/j.1478-3231.2007.01540.x. Liver Int. 2007. PMID: 17919233 Clinical Trial.
No beneficial effects of amantadine in treatment of chronic hepatitis C patients.
van Soest H, van der Schaar PJ, Koek GH, de Vries RA, van Ooteghem NA, van Hoek B, Drenth JP, Vrolijk JM, Lieverse RJ, Houben P, van der Sluys Veer A, Siersema PD, Schipper ME, van Erpecum KJ, Boland GJ. van Soest H, et al. Among authors: van hoek b, van erpecum kj, van der schaar pj, van der sluys veer a, van ooteghem na. Dig Liver Dis. 2010 Jul;42(7):496-502. doi: 10.1016/j.dld.2009.10.006. Epub 2009 Dec 16. Dig Liver Dis. 2010. PMID: 20018575 Clinical Trial.
The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes.
Baven-Pronk AM, Coenraad MJ, van Buuren HR, de Man RA, van Erpecum KJ, Lamers MM, Drenth JP, van den Berg AP, Beuers UH, den Ouden J, Koek GH, van Nieuwkerk CM, Bouma G, Brouwer JT, van Hoek B. Baven-Pronk AM, et al. Among authors: van buuren hr, van hoek b, van erpecum kj, van den berg ap, van nieuwkerk cm. Aliment Pharmacol Ther. 2011 Aug;34(3):335-43. doi: 10.1111/j.1365-2036.2011.04727.x. Epub 2011 Jun 12. Aliment Pharmacol Ther. 2011. PMID: 21668459
Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission.
van Gerven NM, Verwer BJ, Witte BI, van Hoek B, Coenraad MJ, van Erpecum KJ, Beuers U, van Buuren HR, de Man RA, Drenth JP, den Ouden JW, Verdonk RC, Koek GH, Brouwer JT, Guichelaar MM, Mulder CJ, van Nieuwkerk KM, Bouma G; Dutch Autoimmune Hepatitis Working Group. van Gerven NM, et al. Among authors: van buuren hr, van nieuwkerk km, van hoek b, van erpecum kj. J Hepatol. 2013 Jan;58(1):141-7. doi: 10.1016/j.jhep.2012.09.009. Epub 2012 Sep 16. J Hepatol. 2013. PMID: 22989569
252 results